Taming of the Flu: Working Through the Tamiflu Patents in India
National Law School of India University
Solicitor - Supreme Court of England and Wales
Journal of Intellectual Property Rights, Vol. 2, p. 113, March 2006
With an impending Avian influenza or bird flu pandemic, the issue of patents and public health has once again taken centre stage. Oseltamivir (known by its brand name 'Tamiflu'), a patented antiviral pill, has emerged as the world's first line of defence against bird flu. A key priority for most nations is to create sufficient stockpiles of this pill that can then be easily distributed and administered during a pandemic. Keeping this end in mind, this paper explores the patent position in India and looks at ways to work around a patent, should one issue in future. The paper recommends various strategies for creating an optimal and affordable stockpile and calls on the government to take a more definite stand in the matter.
Number of Pages in PDF File: 24
Keywords: bird flu, patents, india, roche, cipla, compulsory licensing
JEL Classification: O34, K00
Date posted: March 21, 2006
© 2015 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo8 in 0.328 seconds